Trials
Hemos
Congenital
Eponyms
Drugs
100
In this trial prophylactic ICD in patients with symptomatic systolic heart failure due to NICCM was not associated with a reduction in all‑cause death but did significantly reduce sudden cardiac death, especially in younger patients.
DANISH trial
100
CO L/min √peak to peak gradient in mmHg
Hakki's equation for AVA
100
25% of Ebstein's anomaly patients have this conduction abnormality
-Accessory pathway
100
In patients with coarctation there is 5-fold increased risk of this cerebrovascular abnormality-
Intracranial aneurysm
100
Half – life of Tc99 m
– 6hrs
200
The _____ Trial showed benefits of this oral soluble guanylate cyclase stimulator - vericiguat in 5,050 high-risk patients with chronic heart failure and reduced ejection fraction (HFrEF <45%) who experienced a recent worsening event.
VICTORIA Trial
200
P1 - P2 = 4V2
Modified bernoulli's equation
200
Bulboventricular loop, morphologic RV on right
-d loop
200
Migratory thrombophlebitis in a patient with abdominal cancer
-Trousseau's sign
200
Treatment of acute dynamic VLOT obstruction
– beta blockers, IV fluids
300
Among patients with advanced heart failure, implantation of a fully magnetically levitated centrifugal-flow pump was associated with better outcomes at 6 months than was implantation of an axial-flow pump, primarily because of the lower rate of reoperation for pump malfunction."
Momentum 3 trial
300
Transpulmonary gradient formula =
MPAP - PCWP
300
uring RVOT repair surgery for TOF, surgeon should be cautious of this coronary anomaly
-Anomalous LAD arising from Right coronary cusp and crossing in front of
RVOT [10%]
300
____ a rare, severe X-linked genetic disorder that primarily causes weakening and thickening of the heart muscle (cardiomyopathy), skeletal muscle weakness, and sometimes intellectual disabilities
Danon disease
300
Non-iodinated derivative of amiodarone
-Dronedarone
400
This trial evaluated Abbott's TriClip system as a minimally invasive option to treat severe tricuspid regurgitation (a leaky tricuspid heart valve) without open-heart surgery
The TRILUMINATE Trial
400
In prosthetic mitral valve, functional obstruction suggested by this PHT
130 msec
400
Ascending aorta to Right Pulmonary artery shunt
- Waterson shunt
400
Autosomal dominant condition which affects bones in the arms and hands, and may also cause hearing problems
Holt Oram syndrome, chromosome 12, TBX5 gene mutation
400
Drug with hemorheological effect [im-proves RBC deformability] used for treatment of PAD
- Pentoxifylline
500
A clinical triad of joint conditions, progressive skeletal myopathy, and cardiac manifestations which include cardiomyopathy, brady and tachy arrhythmias.
Emery-Dreifuss muscular dystrophy
500
Scoring system to ascertain the probability of success of tricuspid clip
GLIDE score
500
Arterial switch procedures for surgical treatment of transposition
- Jatene procedure
500
65 yo M with HTN and chest pressure at rest.
de Winter ECG pattern
500
The mechanism of pro arrhythmia in digoxin toxicity, CPVT which is non-pause dependent is
-Calcium overload / Delayed after depolarization.